ZyVersa Therapeutics, Inc.
ZVSA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001859007
No open-market purchases or sales by ZyVersa Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in ZyVersa Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +1 vs. Q2 2023
- Shares held
- 1.24M
- +938.8K (+316.0%) vs. Q2 2023
- Total value
- $161.8K
- +$88.4K (+120.5%) vs. Q2 2023
- New holders
- 6
- 2 more added
- Sold out
- 5
- 0 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZVSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $1 |
| Q2 2025 | 6 | $44.7K |
| Q1 2025 | 7 | $43.9K |
| Q4 2024 | 8 | $86.2K |
| Q3 2024 | 6 | $7.22K |
| Q2 2024 | 4 | $38.7K |
| Q1 2024 | 8 | $84.9K |
| Q4 2023 | 6 | $181.4K |
| Q3 2023 | 12 | $161.8K |
| Q2 2023 | 11 | $73.4K |
| Q1 2023 | 6 | $273.5K |
| Q4 2022 | 2 | $123.9K |
| Q3 2022 | 29 | $73.3M |
| Q2 2022 | 25 | $62.2M |
| Q1 2022 | 21 | $55.4M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding ZyVersa Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Walleye Capital LLC | 980,568 | $128.5K | 0.00% | +980,568 | New |
| Geode Capital Management, LLC | 123,130 | $16.1K | 0.00% | +123,130 | New |
| Cowen and Company, LLC | 50,000 | $6.47K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 17,194 | $2.23K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 16,709 | $2.19K | 0.00% | +16,709 | New |
| Millennium Management LLC | 15,190 | $1.99K | 0.00% | +15,190 | New |
| Susquehanna International Group, LLP | 13,537 | $1.77K | 0.00% | +13,537 | New |
| Winthrop Advisory Group LLC | 13,361 | $1.73K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,766 | $750 | 0.00% | +20+0.3% | Added |
| Wells Fargo & Company | 161 | $21 | 0.00% | +52+47.7% | Added |
| UBS Group AG | 107 | $14 | 0.00% | +107 | New |
| Bank of America Corp | 100 | $13 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −120,377−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −39,498−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −36,870−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |